1.Recent advances in treatment of wet age-related macular degeneration
International Eye Science 2015;(2):251-254
Age-related macular degeneration ( AMD ) is one of the important eye diseases of the WHO present three big blindness, is one of the main blinding eye disease in people over the age of 50, people over the age of 65, about 2% of the disease caused by monocular blindness, as the population ages, AMD prevalence is increasing in our country. AMD with respect to its clinical manifestations can be divided into dry AMD and wet AMD, wet AMD is the most harmful for the vision of patients, at present there are many treatments for AMD ( mainly for wet age-related macular degeneration ) , mainly including laser treatment, drug therapy, surgical treatment, gene therapy, etc. The treatments of AMD would be illuminated in this article.
2.Animal models and antifibrotic therapy of hepatic fibrosis
Chinese Pharmacological Bulletin 1986;0(05):-
Hepatic fibrosis is a wound-healing response to liver injury, which has complex celluar and molecular mechanisms. Animal models that similar to human hepatic fibrosis are important to explore further pathological mechanisms and more effective drug therapy for hepatic fibrosis. This article reviews recent progress in animal models and antifibrotic therapy related to hepatic fibrosis.
3.Angiogenesis in rheumatoid arthritis
Chinese Pharmacological Bulletin 2003;0(10):-
Indices of angiogenesis are increased in synovia from patients with rheumatoid arthritis, and vascu-lar proliferation may contribute to the pathogenesis of synovitis, pan nus growth, bone and cartilage destruction, and osteophyte formation. Many proan giogenic factors are expressed in the synovium in RA. They have been shown to ha ve important effects in the angiogenic process in RA. So the blockade of angioge nesis appears to be a promising avenue for the future treatment of RA.
4.Reinfusion of autologous drainage blood after total hip replacement under the application of anticoagulant
Chinese Journal of Tissue Engineering Research 2014;(44):7066-7070
BACKGROUND:Reinfusion of autologous drainage blood could reduce al ogeneic blood demand after total hip replacement. The application of anticoagulant could ensure the safety of peri-operation period after total hip replacement. <br> OBJECTIVE:To investigate the application effect of reinfusion of autologous drainage blood after total hip replacement in patients taking anticoagulant. <br> METHODS:100 patients underwent initial unilateral total hip replacement in the Weifang People’s Hospital in China from January 2012 to January 2014. According to reinfusion of autologous drainage blood, the patients were divided into observation group and control group (n=50). <br> RESULTS AND CONCLUSION:After replacement, total blood volume and the maximum mid-thigh circumference change were significantly larger in the observation group than in the control group (P<0.05). No significant difference in hidden blood loss was detected between the two groups (P>0.05). Results indicated that under the application of anticoagulant, reinfusion of autologous drainage blood in patients undergoing total hip replacement does not affect hidden blood loss, but can cause an increase in limb swel ing.
5.Tyk2 signaling plays a critical role in the development of T cytotoxic 1 responses following chronic rBCG-OVA infections in mice
Chinese Journal of Microbiology and Immunology 2011;31(1):41-46
Objective To elucidate potential roles of tyrosine kinase 2 (Tyk2) in the generation and maintenance of Ag-specific CD8+ T cells. Methods We followed the fate of OVA-specific CD8 + T cells in Tyk2-deficient ( Tyk2 -/- ) mice after infection with recombinant OVA-expressing BCG ( rBCGOVA ). Because the immunostimulatory BCG-derived peptides recognized by CD8 + T cells have not been defined, and the OVA is definite peptide for specific CD8 + T cells that has been accepted widely, therefore we examine the kinetics of the OVA-Ag-specific CD8 + T cell response after rBCG-OVA infection in mice.Tyk2-/- and wild type(Tyk2+/+ ) mice were inoculated with rBCG-OVA by intra-trachea( i. t. ), after the examination of bacterial growth in the lung and spleen, the population of CD8 + T cells were detected by FACS analysis, the epitope-specific CD8 + T cells were followed with tetrameric H-2Kb molecule folding with OVA257 264 peptide, and the kinetics of Ag-specific CD8 + Tc1 cells were detected by intracellular IFN-γ production in response to OVA257-264 peptide by cytokine FACS analysis. Results After rBCG-OVA challenge,the bacteria number in spleen and lung of Tyk2 -/- mice were significantly larger than those in Tyk2 +/+ mice on days 14, 21 and 49. Almost as same as that in Tyk2+/+ mice, the size of epitope-specific CD8+ T cella with OVA257-264/Kb-tetramer-positive and the CD8 +Tc1 (T eytotoxic 1 )cells positive for intracellular IFN-γ could proliferate to its peak on day 21, then contract and maintain to the memory phase in spleen and lung of Tyk2-/- mice, but the population of CD8+ T cells in spleen and lung of Tyk2 -/- mice were significantly smaller than those in Tyk2+/+ mice on days 21 and 49, the number of epitope-specific CD8+ T cells in spleen and lung of Tyk2 -/- mice were significantly decreased and the frequency of CD8 + Tc1 cells in spleen and lung of Tyk2 -/- mice significantly reduced on day 21,49 and 70 after rBCG-OVA infection. So correspond with the larger number of bacteria in Tyk2-/- mice than those in Tyk2 +/+ mice, the expansion of OVA257-264-specific CD8 + T cells and CD8+ Tc1 response were attenuated in Tyk2 -/- mice following rBCG-OVA infection. Conclusion These results suggest that the lack of Tyk2 signaling impairs the proliferation and difference of effector CD8 + T cell to rBCG-OVA infection and at least, is partly responsible for the susceptible to the rBCG-OVA infection.
6.Advances of the relationship between Tob1 and tumors
Cancer Research and Clinic 2010;22(11):789-791
Tob1 is a member of Tob/BTG anti-proliferative proteins family. Studies have shown that Tobl involves in tumor development, embryonic development, hyperostosis, behavioral capacity and so on.Tobl is intimate with tumor occurrence and development, and plays an important role in suppressing tumor development. The article focuses on the biological characteristics of the Tob1 and its relationship with tumors.
7.Clinical research on 32 cases of gastrointestinal stromal tumor
International Journal of Surgery 2013;40(10):669-671
Objective Analyzed 32 cases of gastrointestinal stromal tumors(GIST) patients,to analysis the clinical and pathological characteristics of gastrointestinal stromal tumors of the stomach and explore associated prognostic factors.Methods Thirty-two GIST patients confirmed pathologically were included from May,2007 to April,2013.Their clinical records were retrospectively analyzed.Results Of the 32 GIST patients,the overall survival (OS) is 85.3% for the second year.The progression free survival (PFS) is 79.2% for the second year,respectively.Univariate survival analysis showed that OS and PFS have significant association with tumor size,metastasis,mitotic index and NIH risk group.Conclusions Metastasis and NIH risk group both are potential prognostic factor for gastric GIST.
8.Clinical analysis of montelukast combined with doxofylline in older bronchial asthma
Chinese Journal of Postgraduates of Medicine 2013;36(30):14-16
Objective To observe the clinical effect of orally montelukast combined with doxofylline in older bronchial asthma.Methods A total of 87 stationary phase older bronchial asthma patients were divided into trial group (44 cases) and control group (43 cases).Trial group was given orally montelukast 10 mg 1 time/d,doxofylline 0.2 g,2 times/d.Control group was given inhaled fluticasone 250 μ g,2 times/d,a total of 3 months.The forced expiratory volume in one second (FEV1),peak expiratory flow rate (PEFR),one second rate (FEV1/FVC),asthma control test (ACT) score and the adverse reaction were compared between the 2 groups.Results There were no significant differences in FEV1,PEFR,FEV1/FVC before treatment between the 2 groups (P > 0.05),they were significantly improved after treatment [trial group:(2.20 ± 3.21)L vs.(1.68 ± 0.71) L,(3.97 ± 0.32) L/s vs.(3.27 ± 0.32) L/s,(76.18 ± 1.02)% vs.(63.91 ± 1.40)%,control group:(2.24 ±0.75) L vs.(1.71 ± 1.58) L,(4.06 ±0.34) L/s vs.(3.29 ±0.28) L/s,(77.85 ±0.67)% vs.(62.37 ± 1.29)%],there were statistical differences (P < 0.05).But there were no statistical differences after treatment between the 2 groups (P> 0.05).According ACT score,total effective rate in trial group was 90.9% (40/44),in control group was 95.3%(41/43),there was no statistical difference (P > 0.05).The rates of adverse reaction in trial group and control group were 4.5%(2/44) and 7.0%(3/43),there was no statistical difference (P > 0.05).Conclusions The curative effect of orally montelukast combined with doxofylline in older bronchial asthma closes to the classic solution of inhalation fluticasone,which is easily accepted by older patients,and safety.It provides another option for older bronchial asthma patients.
9.Clinical Observation of Severe Bronchial Asthma Treated by aerosol inhalation of Pulmicort Respules combined with urbason
Chinese Journal of Primary Medicine and Pharmacy 2012;(8):1166-1167
ObjectiveTo investigate the efficacy of aerosol inhalation of Pulmicort Respules combined with urbason in treating severe bronchial asthma.MethodsThe clinical data of 40 cases aith severe bronchial asthma treated in our hospital were analyzed retrospectively,among which 20 cases underwent Pulmicort Respules combined with urbason(Tset Group),20 cases underwent urbason( Control Group).ResultsCompared with the control group,the blood gas analysis in test group had statistically significant difference before treatment (P < 0.05 ).Compared with the control group,the clinical effect and the blood gas analysis in test group had no statistically significant difference after treatment(P > 0.05 ).Compared with the control group,the complications in test group had statistically significant difference( P < 0.05),the complications in test group was less than the control group.ConclusionAerosol inhalation of Pulmicort Respules can reduce the amount of urbason and lower the incidence d complications.The combination treatment of this two drugs can achieve the same clinical results alike the clinical effect of large doses of methy lprednisolone.
10.Research progress of the roles of Polo-like kinase 1 in cell mitosis
Cancer Research and Clinic 2014;26(7):494-497
Polo-like kinase 1 (Plk1) is a serine/threonine kinase that is widely expressed in eukaryotic cells and a key regulator of the cell mitosis.During different stages of mitosis,the locations of Plk1 in cells are different,and can interaction with different substrates,thus it has many biological functions.This article focuses on the functions of Plk1 in different mitotic stages.